You searched for Antibody candidate - Page 43 of 69

Interview 17 Jul 2017

Pinning Down Elusive Targets: Interviewing the Co-Founder & CSO of Heptares

…of GPCRs are activated by hormones,” said Marshall, “and endocrine diseases are an example of smaller indications where we can more easily take candidates through all the way to the…

July 17, 2017 - 6 minutesmins - By Evelyn Warner

News and Trends 4 Apr 2023

iNtRON looks to control colorectal cancer through microbiome

iNtRON Biotechnology has announced that it has demonstrated the effectiveness of P18-BE3CRC using a cancer organoid model. P18-BE3CRC is a drug candidate from iNtRON Biotechnology’s PHAGERIA platform technology, which is…

April 4, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 27 Jun 2022

OneThree Biotech completes build and optimization of AI model for RSV data

…infection and then identify drugs that can effectively reverse those signatures with therapeutically meaningful benefits with a view to then adding such identified drugs to Poolbeg’s pipeline. Producing candidates quickly…

June 27, 2022 - 4 minutesmins - By Jim Cornall

In Depth 18 Mar 2024

Will the US biotech funding surge trigger a renaissance in the global biotech industry?

…drug candidates in advanced stages of development. The collective move towards IPOs by these companies, following a record high in 2021 and subsequent drop, suggests a cautious yet optimistic outlook…

March 18, 2024 - 10 minutesmins - By Jules Adam

News and Trends 28 Nov 2022

STORM Therapeutics doses first patient with drug targeting solid tumors

…developing new small molecule therapies targeting RNA modifying enzymes (RMEs) for oncology and other diseases. The patient was dosed with STC-15, STORM’s clinical candidate. It is an orally bioavailable, highly…

November 28, 2022 - 2 minutesmins - By Liza Laws

News and Trends 20 Apr 2017

Norway Brings Another Cancer Vaccine to the Clinic

…RAS mutations. TG02 is Targovax’s second vaccine candidate to enter the clinic. Its lead candidate TG01 has recently completed a Phase I/II trial in resected pancreatic cancer and showed off…

April 20, 2017 - 3 minutesmins - By Melanie De Almeida

Best in Biotech 2 Aug 2024

Six epigenetics companies making strides in 2024

…Storm’s lead candidate STC-15 is the first RNA methyltransferase inhibitor to enter the clinic. STC-15 inhibits METTL3, an RNA methyltransferase associated with cancer and other diseases. Phase 1 interim results…

August 2, 2024 - 7 minutesmins - By Roohi Mariam Peter

central nervous system epilepsy parkinsons disease

News and Trends 29 May 2020

Spanish Neurology Biotech Launches with €7.6M Series A

…plans to target a number of different neurological conditions and has three small molecule candidate drugs it plans to develop. Its lead candidate, which is designed to target multiple sclerosis…

May 29, 2020 - 3 minutesmins - By Helen Albert

News and Trends 4 Jan 2023

Aditxt forms Adimune to focus on immune modulation therapies

…drug candidate, ADI-100, which we believe to be extremely promising.” GMP drug substances of the product candidate ADI-100 are slated to enter the product stability testing program in January 2023….

January 4, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 28 Sep 2022

AION Labs launches AI startup to improve drug trials

…efficacy and safety to improve the probability of success of drug candidates in clinical trials. OMEC.AI aims to build a next-generation computational platform that can both identify hidden safety liabilities…

September 28, 2022 - 3 minutesmins - By Jim Cornall

In Depth 3 Apr 2024

Hepatitis B: are we edging closer to a cure?

…positive statistic, the number of preclinical candidates has fallen from 10 to nine, meaning that there are very few next-generation options coming in behind the current crop of clinical candidates….

April 3, 2024 - 9 minutesmins - By Willow Shah-Neville

News and Trends 11 Mar 2022

Microbiome Space in Spotlight as Microbiotica Sets Funding Record

…approaches to developing therapeutic candidates based on the microbiome, such as isolating different strains of beneficial bacteria or attempting to repair the entire gut ecosystem with multi-strain therapeutic candidates. There…

March 11, 2022 - 3 minutesmins - By Victor Kotsev

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Pinning Down Elusive Targets: Interviewing the Co-Founder & CSO of Heptares

iNtRON looks to control colorectal cancer through microbiome

OneThree Biotech completes build and optimization of AI model for RSV data

Will the US biotech funding surge trigger a renaissance in the global biotech industry?

STORM Therapeutics doses first patient with drug targeting solid tumors

Norway Brings Another Cancer Vaccine to the Clinic

Six epigenetics companies making strides in 2024

Spanish Neurology Biotech Launches with €7.6M Series A

Aditxt forms Adimune to focus on immune modulation therapies

AION Labs launches AI startup to improve drug trials

Hepatitis B: are we edging closer to a cure?

Microbiome Space in Spotlight as Microbiotica Sets Funding Record

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!